Oncimmune Plc
(LSE) ONC
This security has been delisted. This page is retained for historical reference.
ONC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowONC Financials
Key Financial Metrics (TTM)
Gross Margin
45%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
4%
Return on Capital
-1%
Return on Assets
-74%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.23M
Operating Income
$3.23M
EBITDA
$3.00M
Operating Cash Flow
$3.38M
Capital Expenditure
$9.00K
Free Cash Flow
$3.39M
Cash & ST Invst.
$846.00K
Total Debt
$5.12M
Oncimmune Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.55M
-36.1%
Gross Profit
$775.00K
+449.1%
Gross Margin
49.90%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
40
N/A
Net Income
$2.53M
+45.6%
EBITDA
$2.34M
+32.0%
Quarterly Fundamentals
Net Cash
$4.28M
+47.6%
Accounts Receivable
$613.00K
N/A
Inventory
$238.00K
N/A
Long Term Debt
$3.29M
+18.8%
Short Term Debt
$1.83M
-76.9%
Return on Assets
-74.01%
N/A
Return on Invested Capital
-1.45%
N/A
Free Cash Flow
$1.21M
+43.6%
Operating Cash Flow
$1.20M
+52.1%